JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB120684

SNC80, delta opioid receptor agonist

Be the first to review this product! Submit a review

|

(2 Publications)

MW 449.64 g/mol, Purity >99%. Highly potent and selective δ opioid receptor agonist (Ki = 9.4 nM). Centrally active following systemic administration. Displays antidepressant activity.
1 Images
Chemical Structure - SNC80, delta opioid receptor agonist (AB120684)
  • Chemical Structure

Lab

Chemical Structure - SNC80, delta opioid receptor agonist (AB120684)

2D chemical structure image of ab120684, SNC80, delta opioid receptor agonist

Key facts

CAS number

156727-74-1

Purity

>99%

Form

Solid

form

Molecular weight

449.64 g/mol

Molecular formula

C<sub>2</sub><sub>8</sub>H<sub>3</sub><sub>9</sub>N<sub>3</sub>O<sub>2</sub>

Nature

Synthetic

Solubility

1 eq. HCl to 100 mM

DMSO to 20 mM

Biological description

Highly potent and selective δ opioid receptor agonist (Ki = 9.4 nM). Centrally active following systemic administration. Displays antidepressant activity.

IUPAC Name

(+)-4-[(αR)-α-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
Ambient
Appropriate long-term storage conditions
Ambient
Storage information
The product can be stored for up to 12 months

Product protocols

Publications (2)

Recent publications for all applications. Explore the full list and refine your search

Scientific reports 10:8585 PubMed32444688

2020

Agonist-induced phosphorylation bar code and differential post-activation signaling of the delta opioid receptor revealed by phosphosite-specific antibodies.

Applications

Unspecified application

Species

Unspecified reactive species

Anika Mann,Sophia Liebetrau,Marie Klima,Pooja Dasgupta,Dominique Massotte,Stefan Schulz

Journal of translational medicine 16:106 PubMed29673358

2018

Contribution of TLR4 signaling in intermittent hypoxia-mediated atherosclerosis progression.

Applications

Unspecified application

Species

Unspecified reactive species

Xianqin Zeng,Rong Guo,Mei Dong,Julia Zheng,Huili Lin,Huixia Lu
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com